Status
Conditions
Treatments
About
This study is designated to test the safety and initial efficacy of the LunGuard's PFT device for reduction of GER.
Enterally-Fed, Sedated and Mechanically Ventilated Critically Ill Patients in the ICU will have the PFT positioned in them and used for feeding of a Nutritional Formula.Samples will be taken by suction on predetermined intervals and analysed for Pepsin A concentration.
The PFT will be removed upon completion of the study's scheduled routine. Patients in the control group will have a standard polyurethane nasogastric device inserted according to standard procedure, which is considered the gold standard.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Informed consent.
Patients who are expected for at least 12 hours to be:
Included are:
Exclusion criteria
Primary purpose
Allocation
Interventional model
Masking
20 participants in 2 patient groups
Loading...
Central trial contact
Adi Ickowicz; Gilat Mor
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal